HPL is committed to transforming local efforts into global achievements. Our first step toward international collaboration was a licensing agreement with F. Hoffmann-La Roche Limited, Basel, Switzerland.
In 2005, we further expanded our international presence by signing an agreement with Novartis (Sandoz) Bangladesh Limited, allowing us to produce their products at our facility under a toll manufacturing agreement. That same year, we successfully passed a global quality audit by Roche, Switzerland, marking the beginning of our exports to several Asian countries, including Myanmar, Vietnam, Sri Lanka, Hong Kong, and Bhutan. We have also established strategic partnerships with various countries across Africa, ASEAN, and the CIS regions.
HPL is currently in the process of securing GMP approvals from esteemed regulatory bodies such as UKMHRA, TGA, and GCC. We continue to leverage our expertise to explore global opportunities and strengthen international collaborations.
HPL Operates its products in more than 32 countries worldwide
